This is my BMJ Rapid Response, of the 6th January 2018 to Mike Thompson, CEO of the ABPI. [Association of the British Pharmaceutical Industry] I share Mike Thompson’s disappointment in some aspects … Continue reading Exposure to industry promotional activity can lead to doctors recommending worse treatments for patients
On the 5th of December 2017 the Scottish Parliament considered two matters relating to NHS Scotland. In the morning, Sir Harry Burns presented his review on Targets to the Health … Continue reading Who are these folk up the hill?
This post is based on the following Scottish Parliamentary debate which took place on the 5th December 2017. In this post I have highlighted cross-party considerations relating to fully informed … Continue reading Fully informed consent: NHS Scotland
The June 2017 Agenda of the Royal College of Psychiatrists Psychopharmacology Committee confirms that a discussion on ‘involuntary addiction to prescription medications’ was scheduled. My view is that such discussions … Continue reading Psychopharmacology Committee (Strategy Meeting)